Screener
Xenetic Biosciences XBIO Q1 2025 Annual earnings
Reported May 13, 2025 · Before market open
Revenue$593.3KBeat by $77.3K
EPS-$0.59Beat by $0.13
Revenue estimate$516.0K
EPS estimate-$0.72
Next report
Nov 6, 2026 (in 2 months)Versus estimates
Revenue
Q2 2026$660.6KQ1 2026$806.9KQ4 2025$766.3KBeat by $76.3KQ3 2025$1.0MBeat by $397.0KQ2 2025$589.9KBeat by $110.9K
Q1 2025$593.3KBeat by $77.3K
Diluted EPS
Q2 2026-$0.41Q1 2026-$0.20Q4 2025-$0.22Beat by $0.30Q3 2025-$0.33Beat by $0.16Q2 2025-$0.45Beat by $0.19
Q1 2025-$0.59Beat by $0.13
FAQ
- When did Xenetic Biosciences report Q1 2025 earnings?
- Xenetic Biosciences (XBIO) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were Xenetic Biosciences's Q1 2025 revenue and EPS?
- Xenetic Biosciences reported revenue of $593.3K and eps of $-0.59 for Q1 2025.
- Did Xenetic Biosciences beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $516.0K by $77.3K. EPS beat the consensus estimate of $-0.72 by $0.13.
- How did Xenetic Biosciences's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 16.1% from $510.8K a year earlier and eps grew 24.4% from $-0.78.
- Where can I find Xenetic Biosciences's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001683168-25-003513) and the 10-K/A periodic report (0001683168-25-002939) directly on SEC EDGAR. The filing index links above go to sec.gov.
